About this trial
Exploring the effect of protective ileostomy compared with transverse colostomy on the occurrence of complications, the occurrence of serious side effects of adjuvant chemotherapy and disease recurrence in patients with low rectal cancer after radical surgery from the perspective of intestinal microecology.
Eligibility criteria
Qualifiers
Pathological confirmed adenocarcinoma of the rectum;
Patients age between 18-80;
Baseline AJCC stage I-III: cT1-4N0-2M0 (AJCC-8 version);
Eastern Cooperative Oncology Group (ECOG) physical status score of 0 to 2;
Disqualifiers
Other types of rectal cancer (adenosquamous carcinoma, squamous carcinoma, neuroendocrine tumors, clear cell carcinoma, spindle cell carcinoma, undifferentiated carcinoma);
Combination of rectal cancer with multiple carcinomas;
Pre-operative presence of acute and chronic infectious diseases or foci of infection;
Intraoperative radical surgery was not performed for various reasons;
Trial design
Treatments tested in this trial
- Ileostomy
- Transverse colostomy